Table 1.

Demographics, risk factors and baseline characteristics in groups 1 and 2 and healthy controls

	Group 1 (n = 10)	Group 2 (n = 10)	P value	Healthy controls (n = 20)
Male	10	10		12
Female	2	3		8
Age, mean ± SD, years	48.6±7.1	48.1±9.1	0.24	49.6±5.6
Average time to stroke onset, months	11.6	10.5
Risk factors
Hypertension	7 (70%)	6 (60%)	0.15	12 (60%)
Diabetes mellitus	5 (50%)	3 (30%)	0.87	6 (30%)
Hypercholesterolemia	6 (60%)	4 (40%)	0.56	10 (50%)
Smoking	4 (40%)	4 (40%)	0.49	13 (65%)
Alcohol consumption	3 (30%)	2 (20%)	1.0	5 (25%)
Tobacco abuse	–	–	0.58	3 (15%)
Coronary artery disease	5 (50%)	6 (40%)	–	5 (25%)
Ischemic stroke (subtype)
LA atherosclerosis	4 (40%)	4 (40%)	0.67
CE	4 (40%)	1 (10%)	0.35
SA occlusion	2 (20%)	3 (30%)	0.21
Others	–	2 (20%)	0.81
Laboratory parameters
Baseline
VEGF	366.2±78.6 pg/ml	370.5±91.1ng/ml	0.42
BDNF	18.7±6.6 pg/ml	16.1±7.6 ng/ml	0.56
8 Weeks
VEGF	453.5±89.1pg/ml	408.4±98.4ng/ml	0.96
BDNF	32.8±9.2 pg/ml	27.3±8.9 ng/ml	0.78